North America Sodium-dependent Glucose Cotransporter 2 Market |2027
Market Overview
The North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market is expected to register a CAGR greater than 9% over the forecast period, 2022-2027.
COVID-19 significantly exacerbate Diabetes risks because the virus binds to pancreatic cells that produce insulin and could exert a toxic effect on them. In fact, they point out, studies of the earlier SARS-CoV-1 virus found that many infected patients had increased blood sugar. Drugmakers are rushing to advance potential treatments for the fast-spreading virus outbreak that has infected more people globally and so far, many were killed by the respiratory illness, according to a Reuters tally. SGLT2 inhibitors drug maker, AstraZeneca said “it is committed to finding new solutions to fight COVID-19 by investigating the application of new and existing medicines.”
An FDA-approved group of prescription drugs known as SGLT2 inhibitors is used in combination with diet and exercise to decrease blood sugar levels in persons with type 2 diabetes. SGLT2 inhibitors include canagliflozin, dapagliflozin, and empagliflozin as medications. They can be found as one-ingredient formulations or in mixtures with other diabetic medications like metformin. By encouraging the kidneys to eliminate sugar from the body through the urine, SGLT2 inhibitors reduce blood sugar levels. The FDA has not authorized SGLT2 inhibitors for use in individuals with type 1 diabetes because their safety and effectiveness in these patients have not been shown.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.
Scope of the Report
The North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market is expected to register a CAGR greater than 9% over the forecast period. The North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market is Segmented by Product (Jardiance, Farxiga, and Invokana) and by Geography. The report offers the value (in USD million) for the above segments.
Comments
Post a Comment